CN Patent

CN101084016A — 能够容易穿透生物学障碍的组合物

Assigned to Amryt Endo Inc · Expires 2007-12-05 · 18y expired

What this patent protects

本发明与新型的穿透组合物相关，该组合物含有一个或多个效应物，这些效应物包含在水溶性组合物内，并浸没在疏水介质中，本发明还涉及通过向被作用的个体施用这样的穿透性组合物而治疗或预防疾病的方法。

USPTO Abstract

本发明与新型的穿透组合物相关，该组合物含有一个或多个效应物，这些效应物包含在水溶性组合物内，并浸没在疏水介质中，本发明还涉及通过向被作用的个体施用这样的穿透性组合物而治疗或预防疾病的方法。

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: CN101084016A
Jurisdiction: CN
Classification: —
Expires: 2007-12-05
Drug substance claim: No
Drug product claim: No
Assignee: Amryt Endo Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.